Merck Group reposted this
🌐 NEWS: Positive Results for TGCT Patients in Global Phase III Study 🌐 An investigative treatment being developed by our partner 和誉医药 Abbisko Therapeutics shows potential to meet unmet needs for patients with Tenosynovial Giant Cell Tumor (TGCT). 👉 Read more here: https://lnkd.in/eFsDr8kM #AsOneForPatients #PhaseIII #TGCT #Oncology
Hong Chow
1mo
Congratulations to Yao-Chang Xu and 和誉医药 Team! We look forward to working together to bring this promising drug to patients!
Michael Mandola
1mo
Congratulations to all on this important advancement for patients!
Congratulations!
Congratulations to everyone involved in this spectacular achievement!